Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA PFI-1 GDSC1000 pan-cancer AAC -0.024 0.5
mRNA Gemcitabine gCSI pan-cancer AAC -0.042 0.5
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.022 0.5
mRNA compound 1B CTRPv2 pan-cancer AAC 0.028 0.5
mRNA Nutlin-3 CCLE pan-cancer AAC -0.035 0.5
mRNA PLX4720 GDSC1000 pan-cancer AAC -0.022 0.5
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.023 0.5
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.024 0.5
Download CSV